IL213214A0 - Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases - Google Patents
Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseasesInfo
- Publication number
- IL213214A0 IL213214A0 IL213214A IL21321411A IL213214A0 IL 213214 A0 IL213214 A0 IL 213214A0 IL 213214 A IL213214 A IL 213214A IL 21321411 A IL21321411 A IL 21321411A IL 213214 A0 IL213214 A0 IL 213214A0
- Authority
- IL
- Israel
- Prior art keywords
- cilostazol
- vascular
- treatment
- metabolic diseases
- nitrate derivatives
- Prior art date
Links
- 229960004588 cilostazol Drugs 0.000 title 1
- 208000030159 metabolic disease Diseases 0.000 title 1
- 150000002823 nitrates Chemical class 0.000 title 1
- 230000002792 vascular Effects 0.000 title 1
- 208000019553 vascular disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08170435A EP2194048A1 (en) | 2008-12-02 | 2008-12-02 | Nitrate esters for the treatment of vascular and metabolic diseases |
| PCT/EP2009/066159 WO2010063724A1 (en) | 2008-12-02 | 2009-12-01 | Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL213214A0 true IL213214A0 (en) | 2011-07-31 |
Family
ID=40456966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL213214A IL213214A0 (en) | 2008-12-02 | 2011-05-30 | Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8426597B2 (https=) |
| EP (2) | EP2194048A1 (https=) |
| JP (1) | JP2012510502A (https=) |
| KR (1) | KR20110088598A (https=) |
| CN (1) | CN102245583A (https=) |
| AU (1) | AU2009324123A1 (https=) |
| BR (1) | BRPI0923300A2 (https=) |
| CA (1) | CA2745252A1 (https=) |
| IL (1) | IL213214A0 (https=) |
| MX (1) | MX2011005744A (https=) |
| RU (1) | RU2011126607A (https=) |
| SG (1) | SG171423A1 (https=) |
| WO (1) | WO2010063724A1 (https=) |
| ZA (1) | ZA201104011B (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011131613A1 (en) | 2010-04-19 | 2011-10-27 | Cardiolynx Ag | Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases |
| AR081268A1 (es) | 2010-06-02 | 2012-07-18 | Cardiolynx Ag | Derivados de nitrato de pioglitazona |
| ES2691092T3 (es) | 2012-08-21 | 2018-11-23 | Janssen Pharmaceutica Nv | Anticuerpos contra la risperidona y uso de los mismos |
| CN104837838A (zh) | 2012-08-21 | 2015-08-12 | 詹森药业有限公司 | 帕潘立酮半抗原 |
| PL2888592T3 (pl) | 2012-08-21 | 2018-03-30 | Janssen Pharmaceutica Nv | Przeciwciała względem kwetiapiny i ich zastosowania |
| CA2882596C (en) | 2012-08-21 | 2019-05-14 | Ortho-Clinical Diagnostics, Inc. | Antibodies to olanzapine and use thereof |
| WO2014031656A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to olanzapine haptens and use thereof |
| JP6131414B2 (ja) | 2012-08-21 | 2017-05-24 | ヤンセン ファーマシューティカ エヌ．ベー． | アリピプラゾールのハプテン及びイムノアッセイにおけるそれらの使用 |
| CA2882562C (en) | 2012-08-21 | 2019-08-27 | Eric Hryhorenko | Antibodies to aripiprazole and use thereof |
| JP2015527365A (ja) | 2012-08-21 | 2015-09-17 | オルソ−クリニカル ダイアグノスティクス，インコーポレイティド | パリペリドンに対する抗体及びその使用 |
| ES2669565T3 (es) | 2012-08-21 | 2018-05-28 | Janssen Pharmaceutica Nv | Haptenos de risperidona y paliperidona |
| PL2888257T3 (pl) | 2012-08-21 | 2018-02-28 | Janssen Pharmaceutica Nv | Hapteny kwetiapiny do zastosowania w testach immunologicznych |
| JP2015529199A (ja) | 2012-08-21 | 2015-10-05 | オルソ−クリニカル ダイアグノスティクス，インコーポレイティド | パリペリドンハプテンに対する抗体及びその使用 |
| CN104854110B (zh) | 2012-08-21 | 2016-12-28 | 詹森药业有限公司 | 奥氮平半抗原 |
| EP2888284B1 (en) | 2012-08-21 | 2022-07-06 | Janssen Pharmaceutica NV | Antibodies to risperidone haptens and use thereof |
| JP6389176B2 (ja) | 2012-08-21 | 2018-09-12 | ヤンセン ファーマシューティカ エヌ．ベー． | アリピプラゾールハプテンに対する抗体及びその使用 |
| JP6450314B2 (ja) | 2012-08-21 | 2019-01-09 | ヤンセン ファーマシューティカ エヌ．ベー． | クエチアピンハプテンに対する抗体及びその使用 |
| EP3390449A1 (en) | 2015-12-17 | 2018-10-24 | Janssen Pharmaceutica N.V. | Antibodies to risperidone and use thereof |
| US10435478B2 (en) | 2015-12-17 | 2019-10-08 | Janssen Pharmaceutica Nv | Antibodies to quetiapine and use thereof |
| CN114044766B (zh) * | 2021-10-09 | 2022-12-27 | 张北北九食品检验技术有限公司 | 放射性同位素碳-14标记的呋虫胺和中间体及其制备方法和应用 |
| CN120441542B (zh) * | 2025-05-08 | 2025-09-30 | 安徽益普克医药科技发展有限公司 | 一种西洛他唑衍生物及其制备方法与用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5535019A (en) | 1978-09-01 | 1980-03-11 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
| DE122007000050I1 (de) | 1990-02-19 | 2007-11-08 | Novartis Ag | Acylverbindungen |
| US6148496A (en) | 1999-04-09 | 2000-11-21 | The Procter & Gamble Company | Method for making a seamless apertured metal belt |
| IT1311924B1 (it) | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| PL379420A1 (pl) | 2003-07-31 | 2006-09-04 | Nicox S.A. | Pochodne blokerów receptora angiotensyny II |
| WO2006079610A1 (en) * | 2005-01-31 | 2006-08-03 | Nicox S.A. | Nitrooxy sartan derivatives as angiotensin ii receptor blockers for the treatment of cardiovascular and inflammatory diseases |
| EP1922069A2 (en) * | 2005-08-08 | 2008-05-21 | Nitromed, Inc. | Nitric oxide enhancing angiotensin ii antagonist compounds, compositions and methods of use |
-
2008
- 2008-12-02 EP EP08170435A patent/EP2194048A1/en not_active Withdrawn
-
2009
- 2009-12-01 BR BRPI0923300A patent/BRPI0923300A2/pt not_active Application Discontinuation
- 2009-12-01 EP EP09793498A patent/EP2367803A1/en not_active Withdrawn
- 2009-12-01 MX MX2011005744A patent/MX2011005744A/es not_active Application Discontinuation
- 2009-12-01 KR KR1020117015258A patent/KR20110088598A/ko not_active Withdrawn
- 2009-12-01 RU RU2011126607/04A patent/RU2011126607A/ru unknown
- 2009-12-01 US US13/131,722 patent/US8426597B2/en not_active Expired - Fee Related
- 2009-12-01 WO PCT/EP2009/066159 patent/WO2010063724A1/en not_active Ceased
- 2009-12-01 CA CA2745252A patent/CA2745252A1/en not_active Abandoned
- 2009-12-01 JP JP2011538999A patent/JP2012510502A/ja not_active Ceased
- 2009-12-01 SG SG2011038213A patent/SG171423A1/en unknown
- 2009-12-01 CN CN200980149072XA patent/CN102245583A/zh active Pending
- 2009-12-01 AU AU2009324123A patent/AU2009324123A1/en not_active Abandoned
-
2011
- 2011-05-30 IL IL213214A patent/IL213214A0/en unknown
- 2011-05-31 ZA ZA2011/04011A patent/ZA201104011B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010063724A1 (en) | 2010-06-10 |
| RU2011126607A (ru) | 2013-01-10 |
| EP2194048A1 (en) | 2010-06-09 |
| CN102245583A (zh) | 2011-11-16 |
| ZA201104011B (en) | 2012-02-29 |
| KR20110088598A (ko) | 2011-08-03 |
| MX2011005744A (es) | 2011-06-20 |
| JP2012510502A (ja) | 2012-05-10 |
| BRPI0923300A2 (pt) | 2019-07-16 |
| AU2009324123A1 (en) | 2011-07-21 |
| EP2367803A1 (en) | 2011-09-28 |
| CA2745252A1 (en) | 2010-06-10 |
| US20110230520A1 (en) | 2011-09-22 |
| SG171423A1 (en) | 2011-07-28 |
| US8426597B2 (en) | 2013-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL213214A0 (en) | Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases | |
| IL216399A0 (en) | Pharmaceutical composition for the treatment of heart diseases | |
| IL210856A0 (en) | Combination therapy for the treatment of diabetes and related conditions | |
| IL224544B (en) | Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound | |
| PH12013500892A1 (en) | Composition for use in the prevention and/or treatment of skin conditions and skin diseases | |
| IL209282A (en) | History of n-pipridine-3-yl-2-benzimidazole carboxamide and drugs containing it for the treatment of cardiovascular disease | |
| IL207546A0 (en) | Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases | |
| PL3208612T3 (pl) | Kompozycje i sposoby leczenia chorób o podłożu immunologicznym | |
| PL2118074T3 (pl) | Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego | |
| IL210802A0 (en) | Purin derivatives for use in the treatment of fab-related diseases | |
| EP2318005A4 (en) | NEUROPROTECTIVE AGENTS FOR THE PREVENTION AND TREATMENT OF NEURODEEGENERATIVE DISEASES | |
| IL210810A0 (en) | Compositions for the treatment of pain and/or inflamtion | |
| IL216967B (en) | The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases | |
| PL2340042T3 (pl) | Sposoby i kompozycje do leczenia raka | |
| IL223286A0 (en) | Piperidine derivatives and their use for the treatment of metabolic disorders | |
| IL201189A (en) | Fluorization derivatifrone derivatives used as iron pellets in the treatment of neurodegenerative diseases, their preparation and their pharmaceutical preparations | |
| SI2328417T1 (sl) | Spojine, sestavki in postopki za zdravljenje beta amiloidnih bolezni in sinukleinopatije | |
| IL218143A0 (en) | Substituted heterocyclic derivatives for the treatment of pain and epilepsy | |
| ZA201304822B (en) | Azetidine derivatives useful for the treatment of metabolic and inflimmatory diseases | |
| GB0906159D0 (en) | Drug combination for the treatment of proteostatic diseases | |
| PL2148667T3 (pl) | Stosowanie pochodnych cycloheksanoheksolu w leczeniu chorób oczu | |
| SI2234631T1 (sl) | Spojine in postopki za zdravljenje ĺ˝ilne bolezni | |
| GB0909297D0 (en) | Composition for the treatment of skin conditions | |
| IL213703A (en) | Compounds for the treatment of pain and other diseases | |
| GB0715790D0 (en) | Drug combination for the treatment of sialorrhoea |